Digital Osteoarthritis Care
DigiOA
1 other identifier
interventional
68
1 country
13
Brief Summary
Osteoarthritis (OA) is among the most prevalent and costly diseases, with an estimate of $460 billion in all-cause medical costs. It causes pain and reduced physical function, and with no existing cure, the recommended first-line treatment is information, exercise and weight management if indicated. As the prevalence of OA is expected to increase in the coming years, exploring innovative solutions to maintain economical sustainable treatment in the future becomes a necessity. Telerehabilitation, technology which involves providing treatment through information and communication technology, regardless of the patient's geographical location, has shown its potential within cardiac, pulmonary, neurological and musculoskeletal conditions. Virtual Training (VT) is a generic mobile health application used to deliver digital home exercise programs with text, audio and video support. Through a novel feedback system the therapist is able monitor the patients progress and pain level during exercise. This project aims to investigate, through a randomized controlled trial (RCT), whether the use of the VT-app is as effective as supervised exercise therapy in improving pain, physical function and disease activity in patients with hip and/or knee osteoarthritis. In addition, the investigators want to investigate if the use of the app is more cost effective than supervised exercise therapy, whether the use increases adherence with first line treatment, and whether there are certain characteristics of the patients responding to the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2021
Longer than P75 for not_applicable
13 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 15, 2021
CompletedFirst Posted
Study publicly available on registry
February 23, 2021
CompletedStudy Start
First participant enrolled
June 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedDecember 12, 2024
December 1, 2024
2.6 years
February 15, 2021
December 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of responders according to OMERACT-OARSI responder criteria
A patient is classified as a responder if one of the following criteria is fulfilled: 1. High improvement in pain or function from baseline to follow-up * ≥50% improvement + absolute change of ≥2 in pain, OR * ≥50% improvement + absolute change of ≥2 in function 2. Improvement in at least two of the three following from baseline to follow-up: * ≥20% improvement + absolute change ≥1 in pain * ≥20% improvement + absolute change ≥1 in function * ≥20% improvement + absolute change ≥1 in the patient´s global assessment of disease activity
6 weeks (end of intervention period)
Secondary Outcomes (49)
Number of responders according to OMERACT-OARSI responder criteria
18 weeks post randomization
Physical performance test, 30 seconds sit to stand test (30 sec STS)
Baseline
Physical performance test, 30 seconds sit to stand test (30 sec STS)
6 weeks (end of intervention period)
Self reported goal achievement, Patient-specific functional scale (PSFS)
Baseline
Self reported goal achievement, Patient-specific functional scale (PSFS)
6 weeks (end of intervention period)
- +44 more secondary outcomes
Study Arms (2)
OA school + Virtual Training mobile health application
EXPERIMENTALAfter a clinical examination by the physiotherapist, all patients will receive a 1-2-hour group session of patient education according to guidelines. The intervention group will receive an individually tailored exercise program through the Virtual Training mobile health application. After each exercise the patient score his/her execution of the exercise on a Likert-scale of 1 to 5, judging their effort from very poor to very good. After the session, patients rate their pain on a Numeric Rating Scale from 0 to 10. The patients in the intervention group will be instructed to exercise 3 times per week for 6 weeks. If the patients want to exercise more than 3 times per week, the exercise program will be available in the app once every day.
OA school + usual care
ACTIVE COMPARATORAfter a clinical examination by the physiotherapist, all patients will receive a 1-2-hour group session of patient education according to guidelines. The control group will receive individually tailored supervised exercise therapy by a physiotherapist individually or in a group setting, twice a week for 6 weeks. Additionally, the patients will be motivated to perform one session of home exercise a week, a total of 3 sessions per week
Interventions
Patient education according to guidelines, with information about e.g. disease progression, symptoms, treatment, exercise, self-care techniques and dietary information
Individually tailored home exercise programs delivered through a mobile health application
Individually tailored exercise programs conducted in weekly supervised individual or group sessions
Eligibility Criteria
You may qualify if:
- Activity-related hip and/or knee pain/complaints and clinical signs and symptoms corresponding to hip and/or knee OA
- Access to smartphone or tablet
You may not qualify if:
- Neurological disorders
- Contraindication to physical activity
- Total hip or knee replacement in the actual joint(s) with no pain/ complaints in the other hip or knee joint(s)
- Inflammatory rheumatic diseases (e.g. rheumatoid arthritis, spondyloarthritis)
- Malignant illness or other major conditions (e.g. unstable cardiovascular disorders or lung disease, dementia) that restrict the ability to adhere to the recommended treatment
- Not understanding the Norwegian language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Diakonhjemmet Hospitallead
- The Dam Foundationcollaborator
- The Norwegian Council for Musculoskeletal Healthcollaborator
Study Sites (13)
Laguneparken fysioterapi/Arna fysikalske
Bergen, Norway
Sandviken fysioterapi og trening
Bergen, Norway
Trimmen
Drammen, Norway
Sentrum Fysioterapi
Gjøvik, Norway
Ace Treningssenter
Indre Østfold, Norway
Trøgstad fysioterapi
Indre Østfold, Norway
Nittedal fysikalske institutt
Nittedal, Norway
Physiotherapist Stein Listaul
Notodden, Norway
Aktifys Institutt
Oslo, Norway
Furuset Fysioterapi
Oslo, Norway
Røa Centrum Fysioterapi og Akupunktur
Oslo, Norway
Ski Fysioterapisenter
Ski, Norway
Skiptvet Fysikalske
Skiptvet, Norway
Related Publications (2)
Martinsen L, Osteras N, Moseng T, Tveter AT. Adherence to in-person and app-based exercise for patients with hip or knee osteoarthritis; secondary analyses from a randomized controlled trial. Rheumatol Int. 2025 Aug 26;45(9):208. doi: 10.1007/s00296-025-05967-4.
PMID: 40856813DERIVEDMartinsen L, Osteras N, Moseng T, Tveter AT. Effect of a mHealth exercise intervention compared with supervised exercise therapy in osteoarthritis management: protocol of the DigiOA trial. BMJ Open. 2022 Sep 23;12(9):e066248. doi: 10.1136/bmjopen-2022-066248.
PMID: 36153027DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anne Therese Tveter, PhD
Diakonhjemmet Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Assosiate Professor
Study Record Dates
First Submitted
February 15, 2021
First Posted
February 23, 2021
Study Start
June 1, 2021
Primary Completion
December 31, 2023
Study Completion
December 31, 2025
Last Updated
December 12, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share
Data may be made available on reasonably request to principal investigator